| Mrs Hilary Ann Eppert, MA, CCC-A | |
|
2015 Jackson St, Anderson, IN 46016-4337 | |
| (765) 646-8411 | |
| (765) 646-8412 |
| Full Name | Mrs Hilary Ann Eppert |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 28 Years |
| Location | 2015 Jackson St, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659546869 | NPI | - | NPPES |
| 200512380 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 23002169A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Physicians Of Indiana Inc | 1759416662 | 1319 |
News Archive
K-V Pharmaceutical Company announced today it has been informed by Hologic, Inc. that site initiation and patient enrollment has begun at international clinical trial sites in Europe in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 mg/1 mL), commonly referred to as "17P," for the prevention of preterm birth in women pregnant with a single baby with a history of singleton spontaneous preterm birth.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging. Now, two teams of researchers have developed versatile nanotechnology-enabled platforms that could get therapeutic genes safely and efficiently into cancer cells.
The University of Michigan will join nine other clinical centers across the country working to compare the effectiveness of different treatment strategies for women with uterine fibroids.
Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on Wednesday at the XIX International AIDS Conference in Washington, D.C., joined former Senate Majority Leader Bill Frist (R-Tenn.) for a panel discussion on bipartisanship "focusing on sustaining the engagement of the U.S. Congress in order to demonstrate and encourage continued U.S. leadership in the fight against global AIDS," the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 8 days ago
| Provider Name | Community Physicians Of Indiana Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619105244 PECOS PAC ID: 1759416662 Enrollment ID: O20100317000717 |
News Archive
K-V Pharmaceutical Company announced today it has been informed by Hologic, Inc. that site initiation and patient enrollment has begun at international clinical trial sites in Europe in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 mg/1 mL), commonly referred to as "17P," for the prevention of preterm birth in women pregnant with a single baby with a history of singleton spontaneous preterm birth.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging. Now, two teams of researchers have developed versatile nanotechnology-enabled platforms that could get therapeutic genes safely and efficiently into cancer cells.
The University of Michigan will join nine other clinical centers across the country working to compare the effectiveness of different treatment strategies for women with uterine fibroids.
Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on Wednesday at the XIX International AIDS Conference in Washington, D.C., joined former Senate Majority Leader Bill Frist (R-Tenn.) for a panel discussion on bipartisanship "focusing on sustaining the engagement of the U.S. Congress in order to demonstrate and encourage continued U.S. leadership in the fight against global AIDS," the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 8 days ago
| Provider Name | Ball State University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093937476 PECOS PAC ID: 9830577220 Enrollment ID: O20220525001264 |
News Archive
K-V Pharmaceutical Company announced today it has been informed by Hologic, Inc. that site initiation and patient enrollment has begun at international clinical trial sites in Europe in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 mg/1 mL), commonly referred to as "17P," for the prevention of preterm birth in women pregnant with a single baby with a history of singleton spontaneous preterm birth.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging. Now, two teams of researchers have developed versatile nanotechnology-enabled platforms that could get therapeutic genes safely and efficiently into cancer cells.
The University of Michigan will join nine other clinical centers across the country working to compare the effectiveness of different treatment strategies for women with uterine fibroids.
Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on Wednesday at the XIX International AIDS Conference in Washington, D.C., joined former Senate Majority Leader Bill Frist (R-Tenn.) for a panel discussion on bipartisanship "focusing on sustaining the engagement of the U.S. Congress in order to demonstrate and encourage continued U.S. leadership in the fight against global AIDS," the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Hilary Ann Eppert, MA, CCC-A 2015 Jackson St, Anderson, IN 46016-4337 Ph: (765) 646-8172 | Mrs Hilary Ann Eppert, MA, CCC-A 2015 Jackson St, Anderson, IN 46016-4337 Ph: (765) 646-8411 |
News Archive
K-V Pharmaceutical Company announced today it has been informed by Hologic, Inc. that site initiation and patient enrollment has begun at international clinical trial sites in Europe in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 mg/1 mL), commonly referred to as "17P," for the prevention of preterm birth in women pregnant with a single baby with a history of singleton spontaneous preterm birth.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging. Now, two teams of researchers have developed versatile nanotechnology-enabled platforms that could get therapeutic genes safely and efficiently into cancer cells.
The University of Michigan will join nine other clinical centers across the country working to compare the effectiveness of different treatment strategies for women with uterine fibroids.
Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on Wednesday at the XIX International AIDS Conference in Washington, D.C., joined former Senate Majority Leader Bill Frist (R-Tenn.) for a panel discussion on bipartisanship "focusing on sustaining the engagement of the U.S. Congress in order to demonstrate and encourage continued U.S. leadership in the fight against global AIDS," the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 8 days ago
Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1601 Medical Arts Blvd, Ste 50, Anderson, IN 46011 Phone: 765-683-0752 Fax: 765-683-0752 | |
Hearing Center, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1601 Medical Arts Blvd, Ste 50, Anderson, IN 46011 Phone: 765-298-4190 Fax: 765-298-5826 | |
Judith Ann Correll, AUDIOLOGIST Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1629 Medical Arts Blvd, Suite 200, Anderson, IN 46011 Phone: 765-298-4460 Fax: 765-298-4999 | |
Advanced Hearing Care Audiologist Medicare: Medicare Enrolled Practice Location: 1827 N Madison Ave, Suite C, Anderson, IN 46011 Phone: 765-608-3277 Fax: 765-608-3278 | |
Linda Lupton, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-646-8172 Fax: 765-646-8412 | |
Optiview Vision & Hearing Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4648 S Scatterfield Rd, Anderson, IN 46013 Phone: 765-644-0506 Fax: 765-622-0958 |